Patent assignee · US · COMPANY

ImClone LLC

26Patents
23Active
26Granted
45Portfolio score

Filing activity: May 3, 2004 → Aug 11, 2015 · 13 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7598350B2 Human anti-epidermal growth factor receptor antibody Chemistry; Metallurgy 35 Expired
US7740850B2 PDGFRβ-specific antibodies Chemistry; Metallurgy 20 Active
US8552157B2 c-Kit antibodies and uses thereof Chemistry; Metallurgy 19 Active
US8071099B2 Anti-FLT3 antibodies Chemistry; Metallurgy 10 Active
US8043618B2 Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment Chemistry; Metallurgy 10 Active
US7947811B2 Antibodies that bind specifically to human RON protein Chemistry; Metallurgy 9 Active
US8128929B2 Antibodies against PDGFRa Chemistry; Metallurgy 8 Active
US8404240B2 Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment Chemistry; Metallurgy 7 Active
US7972596B2 Antibodies against vascular endothelial growth factor receptor-1 Chemistry; Metallurgy 7 Expired
US8263079B2 Antibodies against CSF-1R Chemistry; Metallurgy 6 Active
US7638605B2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor Chemistry; Metallurgy 5 Expired
US8263074B2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof Chemistry; Metallurgy 5 Active
US7968093B2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor Chemistry; Metallurgy 3 Active
US8133489B2 Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof Chemistry; Metallurgy 2 Active
US8147834B2 Anti-TGF-beta receptor II antibodies Chemistry; Metallurgy 2 Active
US8057791B2 Human antibodies specific to KDR and uses thereof Chemistry; Metallurgy 1 Active
US8182815B2 Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment Chemistry; Metallurgy 1 Active
US9375488B2 Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment Physics 1 Active
US8143025B2 Antibodies against vascular endothelial growth factor receptor-1 Chemistry; Metallurgy 1 Active
US8481034B2 Anti-VEGFR-3 antibody compositions Chemistry; Metallurgy 0 Active
US8574578B2 Antibodies against PDGFRα to inhibit tumor growth Chemistry; Metallurgy 0 Active
US8784818B2 Anti-VEGFR-3 antibody compositions Chemistry; Metallurgy 0 Active
US10766961B2 Anti-VEGFR2 antibody therapy for hepatocellular carcinoma Physics 0 Active
US7951370B2 Anti-TYRP1 antibodies Chemistry; Metallurgy 0 Active
US8425911B2 Methods of treating secondary bone tumors with antibodies against PDGFR alpha Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.